https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-01-31 / Expert Opin Drug Discov 2023 Jan;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-01-31 / Expert Opin Drug Discov 2023 Jan;2023-01-31 00:00:002023-01-31 00:00:00Glioblastoma treatment slowly moves towards change: novel druggable targets and translational horizons in 2022
https://www.iozk.de/wp-content/uploads/2020/11/IOZK_team_van-gool_175828-ret.jpg
518
690
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2023-01-23 16:08:352023-01-25 16:42:45Stefaan van Gool ist Herausgeber einer Sonderausgabe im Journal of Molecular Sciences
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2023-01-20 16:48:372023-01-25 16:59:59Hyperthermie die vierte Säule in der Onkologie – Trailer zum Film
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-01-20 / Medicine (Baltimore) 2023 Jan;102(3):e32727
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-01-20 / Medicine (Baltimore) 2023 Jan;102(3):e327272023-01-20 00:00:002023-02-11 09:54:47Modulated electrohyperthermia in locally advanced cervical cancer: Results of an observational study of 95 patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-01-20 / Strahlenther Onkol 2023 Jan;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-01-20 / Strahlenther Onkol 2023 Jan;2023-01-20 00:00:002023-01-20 00:00:00[Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-01-17 / Biomedicines 2023 Jan;11(2)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-01-17 / Biomedicines 2023 Jan;11(2)2023-01-17 00:00:002023-01-17 00:00:00Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-01-09 / Curr Opin Oncol 2023 Mar;35(2):87-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-01-09 / Curr Opin Oncol 2023 Mar;35(2):87-932023-01-09 00:00:002023-01-09 00:00:00Current „state of the art“ on dendritic cell-based cancer vaccines in melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-01-04 / Int J Mol Sci 2023 Jan;24(2)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-01-04 / Int J Mol Sci 2023 Jan;24(2)2023-01-04 00:00:002023-01-04 00:00:00Neutrophils in Dendritic Cell-Based Cancer Vaccination: The Potential Roles of Neutrophil Extracellular Trap Formation
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-01-01 / JAMA Oncol 2023 Jan;9(1):112-121
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-01-01 / JAMA Oncol 2023 Jan;9(1):112-1212023-01-01 00:00:002023-05-30 16:23:26Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial
